Abstract:Background: Parkinson's disease (PD) symptoms deteriorate with disease progression. Although deep brain stimulation (DBS) can effectively improve the motor signs of PD patients, it is not yet known whether DBS surgery, which is an invasive treatment modality, may change the progression of PD. Objective: The aim of this work was to compare the effect of DBS with that of drug treatment on the progression of PD. Methods: A total of 77 patients with PD with the Hoehn and Yahr scale (HY) stage of 2.5 or 3 were included, and were divided into 34 in the drug therapy alone group (Drug-G) and 43 in the DBS therapy group (DBS-G). All patients were subjected to a follow-up of 2 years, and disease severity was assessed by the Unified Parkinson's Disease Rating Scale part III (UPDRS-III), the Montreal Cognitive Assessment (MOCA), the Hamilton Anxiety Scale (HAMA), and the Hamilton Depression Scale (HAMD) scores. In addition, the quality of life of patients and the burden on their family were assessed by the 39-item PD questionnaire (PDQ-39) scores, daily levodopa equivalent dose (LED), patient's annual treatment-related costs, and the Zarit Caregiver Burden Scale (ZCBS) score. The changes in relevant scale scores between the two groups were compared at each follow-up stage. Results: The UPDRS-III score of the patients in the "off" state increased from year to year in both groups, and the degree of increase of this score was greater in the DBS-G than in the Drug-G group. The MOCA score in both groups began to decline in the 2nd year of follow-up, and the decline was greater in the Drug-G than in the DBS-G group. DBS treatment did not affect patients' psychiatric disorders. The PDQ39, LED, costs, and ZCBS were negatively correlated with the follow-up time in patients in the DBS-G group, and positively correlated with the follow-up time in patients in the Drug-G. Conclusion: PD is progressive regardless of treatment. The findings from this follow-up study suggest that the disease progression of patients in DBS-G may be slightly faster compared to the drug-G, but the advantages of DBS are also evident. Indeed, DBS better improves patient's motor signs and quality of life and reduces the family burden. In addition, DBS has less impact on patients in terms of cognitive and mental effects.

Subthalamic deep brain stimulation and levodopa in Parkinson’s disease: a meta-analysis of combined effects

Subthalamic and pallidal deep brain stimulation for Parkinson's disease-meta-analysis of outcomes

Subthalamic Nucleus Stimulation for Parkinson's Disease Preferentially Improves Akinesia of Proximal Arm Movements Compared to Finger Movements

The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study

Effects of deep brain stimulation of the subthalamic nucleus on the postoperative antiparkinsonian medication

Effects of subthalamic nucleus deep brain stimulation on the neuropsychological function of patients with Parkinson's disease: A meta-analysis

Deep brain stimulation in Parkinson’s disease: meta-analysis of randomized controlled trials

Metabolic network modulation by bilateral subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease

Comparison of the Long‐Term Efficacy of Targeting the Subthalamic Nucleus Versus the Globus Pallidus Interna for Deep Brain Stimulation Treatment of Motor Dysfunction in Patients With Parkinson's Disease: A Meta‐Analysis Study

Improvement of Subthalamic Nucleus Deep Brain Stimulation in Sleeping Symptoms in Parkinson’s Disease: A Meta-Analysis

Frequency-dependent effects of subthalamic deep brain stimulation on motor symptoms in Parkinson’s disease: a meta-analysis of controlled trials

490 Unilateral Subthalamic Nucleus Deep Brain Stimulation Improves Motor Symptoms Without Neurocognitive Worsening in Parkinsons Disease

General anesthesia versus local anesthesia for deep brain stimulation targeting of STN in Parkinson's disease: A systematic review and meta-analysis

Deep brain stimulation of the subthalamic nucleus improves sleep in Parkinson disease patients: A systematic review and meta-analysis

Effect of deep brain stimulation compared with drug therapy alone on the progression of Parkinson's disease

Dopaminergic therapy and subthalamic stimulation in Parkinson’s disease: a review of 5-year reports

Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson's Disease

Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease

Deep Brain Stimulation of the Subthalamic Nucleus for the Treatment of Parkinson's Disease

The potential neuromodulatory impact of subthalamic nucleus deep brain stimulation on Parkinson's disease progression

Efficacy Comparison of Subthalamic and Globus Pallidus Internus Deep Brain Stimulation in Parkinson's Disease with Dyskinesia